Page last updated: 2024-10-16

5-hydroxytryptophan and Parkinson Disease, Secondary

5-hydroxytryptophan has been researched along with Parkinson Disease, Secondary in 4 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wesemann, W1
Grote, C1
Clement, HW1
Block, F1
Sontag, KH1
Silvestrini, B1
Lisciani, R1
Portmann-Cristesco, EM1
Boissier, JR1
Chase, TN1

Reviews

1 review available for 5-hydroxytryptophan and Parkinson Disease, Secondary

ArticleYear
Serotonergic mechanisms and extrapyramidal function in man.
    Advances in neurology, 1974, Volume: 5

    Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extr

1974

Other Studies

3 other studies available for 5-hydroxytryptophan and Parkinson Disease, Secondary

ArticleYear
Functional studies on monoaminergic transmitter release in parkinsonism.
    Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; A

1993
Experimental data suggesting an adrenergic mechanism in the production of parkinsonian symptoms.
    Current therapeutic research, clinical and experimental, 1976, Volume: 20, Issue:5

    Topics: 5-Hydroxytryptophan; Animals; Atropine; Clonidine; Female; Fenclonine; Imipramine; Male; Mice; Mice,

1976
[Dopamine release in the rat nigrostratum system after hydroxy-5 tryptophan administration].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1974, Feb-11, Volume: 278, Issue:7

    Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Humans; Hydroxyindoleaceti

1974